{
    "eid": "2-s2.0-85042214406",
    "title": "Persistence of hepatitis B immune memory until 9\u201310 years of age following hepatitis B vaccination at birth and DTaP-IPV-HB-PRP\u223cT vaccination at 2, 4 and 6 months",
    "cover-date": "2018-05-04",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology and Allergy",
            "@code": "2723",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        }
    ],
    "keywords": [
        "fully liquid",
        "hepatitis B",
        "hexavalent",
        "immunity persistence",
        "infant",
        "primary series",
        "vaccine"
    ],
    "authors": [
        "Pope Kosalaraksa",
        "Kulkanya Chokephaibulkit",
        "Suwat Benjaponpitak",
        "Chitsanu Pancharoen",
        "Sunate Chuenkitmongkol",
        "Siham B'Chir",
        "Xavier Da Costa",
        "Emmanuel Vidor"
    ],
    "citedby-count": 13,
    "ref-count": 56,
    "ref-list": [
        "DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa): A review of its use as primary and booster vaccination",
        "Review of 8 years of experience with Infanrix hexa (DTPa-HBV-IPV/Hib hexavalent vaccine)",
        "Combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type B vaccine; Infanrix hexa: twelve years of experience in Italy",
        "DTaP-IPV-Hep B-Hib vaccine (Hexyon\u00ae/Haxacima\u00ae): a guide to its use in the primary and booster vaccination of infants and toddlers in Europe",
        "DTaP-IPV-Hep B-Hib vaccine (Hexaxim\u00ae): a review of its use in primary and booster vaccination",
        "Review of a new fully liquid, hexavalent vaccine: Hexaxim",
        "Combined immunogenicity data for a new DTaP-IPV-Hep B-PRP-T vaccine (Hexaxim) following primary series administration at 2, 4, 6 months of age in Latin America",
        "A DTaP-IPV//PRP\u223cT vaccine (Pentaxim): a review of 16 years' clinical experience",
        "Immunogenicity of a two-component (PT & FHA) acellular pertussis vaccine in various combinations",
        "Immunogenicity and safety of a novel yeast Hansenula polymorpha-derived recombinant Hepatitis B candidate vaccine in healthy adolescents and adults aged 10\u201345 years",
        "A fully liquid DTaP-IPV-Hep B-PRP-T hexavalent vaccine for primary and booster vaccination of healthy Mexican children",
        "A fully liquid DTaP-IPV-HB-PRP-T hexavalent vaccine for primary and booster vaccination of healthy Turkish infants and toddlers",
        "Immunogenicity and safety of a liquid hexavalent vaccine in Indian infants",
        "Immunogenicity and safety study of a new DTaP-IPV-Hep B-PRP-T combined vaccine compared to a licensed DTaP-IPV-Hep B//PRP-T comparator, both concomitantly administered with a 7-valent pneumococcal conjugate vaccine at 2, 4, and 6 months of age in Thai infants",
        "Immunogenicity and safety of a fully liquid DTaP-IPV-Hep B-PRP-T vaccine at 2-4-6 months of age in Peru",
        "A randomized, controlled study of a fully liquid DTaP-IPV-HB-PRP-T hexavalent vaccine for primary and booster vaccinations of healthy infants and toddlers in Latin America",
        "Safety and immunogenicity of an investigational fully liquid hexavalent DTaP-IPV-Hep B-PRP-T vaccine at two, four and six months of age compared with licensed vaccines in Latin America",
        "Antibody persistence and booster vaccination of a fully liquid hexavalent vaccine coadministered with measles/mumps/rubella and varicella vaccines at 15\u201318 months of age in healthy South African infants",
        "Immunogenicity and safety of an investigational fully liquid hexavalent combination vaccine versus licensed combination vaccines at 6, 10, and 14 weeks of age in healthy South African infants",
        "Antibody persistence after a primary series of a new DTaP-IPV-Hep B-PRP-T combined vaccine or separate DTaP-IPV//PRP-T and hepatitis B vaccines at 2, 4, and 6 months of age and the effect of a subsequent DTaP-IPV//PRP-T booster vaccination at 18 months of age in healthy Argentinean infants",
        "Immunogenicity and safety of an investigational hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-hepatitis B-Haemophilus influenzae B conjugate combined vaccine in healthy 2-, 4-, and 6-month-old Argentinean infants",
        "Concomitant administration of a fully liquid, ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal serogroup C conjugate vaccine in infants",
        "A randomized, controlled study of DTaP-IPV-HB-PRP-T, a fully liquid hexavalent vaccine, administered in a 3, 5 and 11\u201312 month schedule",
        "Are booster immunisations needed for lifelong hepatitis B immunity? European Consensus Group on Hepatitis B Immunity",
        "Hepatitis B vaccines: WHO position paper\u2013July 2017",
        "Immune persistence after hepatitis B vaccination in infancy\u2013fact or fancy",
        "Long-term persistence of immunity after hepatitis B vaccination: is this substantiated by the literature",
        "Long-term persistence of immunity after hepatitis B vaccination: a fact, not a fancy",
        "Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand",
        "Long-term anti-HBs antibody persistence following infant vaccination against hepatitis B and evaluation of anamnestic response: a 20-year follow-up study in Thailand",
        "Immune memory to hepatitis B persists in children aged 7\u20138 years, who were vaccinated in infancy with 4 doses of hexavalent DTPa-HBV-IPV/Hib (Infanrix hexa) vaccine",
        "Persistence and immune memory to hepatitis B vaccine 20 years after primary vaccination of Thai infants, born to HBsAg and HBeAg positive mothers",
        "Hepatitis B specific T cell immunity induced by primary vaccination persists independently of the protective serum antibody level",
        "Switched memory B cells maintain specific memory independently of serum antibodies: the hepatitis B example",
        "Safety and immune response to a challenge dose of hepatitis B vaccine in healthy children primed 10 years earlier with hexavalent vaccines in a 3, 5, 11-month schedule: an open-label, controlled, multicentre trial in Italy",
        "Challenge with a hepatitis B vaccine in two cohorts of 4-7-year-old children primed with hexavalent vaccines: an open-label, randomised trial in Italy",
        "Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study",
        "Routine newborn hepatitis B immunization: a review of schedules",
        "Hepatitis B immune status in adolescents vaccinated during infancy: a retrospective cohort study from a pediatric practice in Germany",
        "Immunogenicity and reactogenicity of a novel hexavalent DTPa-HBV-IPV/Hib vaccine compared to separate concomitant injections of DTPa-IPV/Hib and HBV vaccines, when administered according to a 3, 5 and 11 month vaccination schedule",
        "Antibody levels and protection after hepatitis B vaccine: results of a 30-year follow-up study and response to a booster dose",
        "Antibody persistence and the effect of a booster dose given 5, 10 or 15 years after vaccinating preadolescents with a recombinant hepatitis B vaccine",
        "Duration of protection after infant hepatitis B vaccination series",
        "Immunity to hepatitis B persists in adolescents 15\u201316 years of age vaccinated in infancy with three doses of hepatitis B vaccine",
        "Two decades of hepatitis B vaccination in mentally retarded patients: effectiveness, antibody persistence and duration of immune memory",
        "Antibody and immune memory persistence post infant hepatitis B vaccination",
        "Long-term T-cell-mediated immunologic memory to hepatitis B vaccine in young adults following neonatal vaccination",
        "Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catch-up immunization program",
        "Observational study of vaccine efficacy 24 years after the start of hepatitis B vaccination in two Gambian villages: no need for a booster dose",
        "Lasting immune memory against hepatitis B following challenge 10\u201311 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11\u201312 months of age",
        "Will infant hepatitis B vaccination protect into adulthood?: Extended Canadian experience after a 2-, 4- and 6-month immunization schedule",
        "Immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine as a booster dose in 12- to 18-month-old children primed with 3 doses of 7-valent pneumococcal conjugate vaccine",
        "Two-sided confidence intervals for the single proportion: comparison of seven methods"
    ],
    "affiliation": [
        {
            "affiliation-city": "Lyon",
            "@id": "60065719",
            "affilname": "Sanofi Pasteur SA",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60065719",
            "affiliation-country": "France"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199578",
            "affilname": "Ramathibodi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199575",
            "affilname": "Siriraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": null,
            "@id": "60021909",
            "affilname": "Srinagarind hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021909",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "106537985",
            "affilname": "Sanofi Pasteur",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/106537985",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "European Medical Writers Association",
        "Sanofi Pasteur, Lyon",
        "Sanofi Pasteur"
    ]
}